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1. Introduction 
MicroRNAs (miRNAs) participate in several biological processes, including development, 
differentiation, apoptosis, and proliferation (1, 2) through imperfect pairing with target 
messenger RNAs (mRNAs) of protein-coding genes and transcriptional or post-
transcriptional regulation of their expression (3, 4). Approaches to miRNA detection, such as 
parallel sequencing technologies may replace conventional sequencing (5). The GS 454 
technology can produce a similar number of longer (100–150-nucleotides (nt)) sequence 
reads in a single analysis run, with the advantage that this method can derive the complete 
sequence of the mature miRNA. Moreover, recent studies on miRNA profiling performed 
with cloning techniques suggest that sequencing methods are suitable for the detection of 
novel miRNAs, modifications, and precise compositions, and that cloning frequencies 
calculated by clone count analysis strongly correlate with the concentrations measured by 
Northern blotting, and are reproducible. The achievement of comprehensive profiling of 
miRNA in human diseases requires exhaustive qualitative and quantitative analyses. Here 
we show the techniques and the some of the results of the miRNA transcriptomes in the 
liver using sequencing. This serves as a critical step in clarifying the functional significance 
of specific miRNAs as they relate to liver diseases. 
2. Techiniques of MicroRNA cloning and bioinformatics for MiRNAome 
2.1. MicroRNA cloning 
The method for microRNA cloning and sequencing that we moderated from the original 
ones are shown in Fig1. We cloned small RNA by a modification of the published miRNA 
cloning protocol of Lagos-Quintana et al. (6). In brief, total RNA samples were extracted 
using ISOGEN (Nippon Gene, Tokyo, Japan), separated in a denaturing polyacrylamide gel, 
and the 18–24 nt fraction was recovered. Next, 5′- and 3′-adapters were ligated to the RNAs 
Ligation of small RNAs with DNA_RNA chimera linkers at both termini [3’ linker 
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oligonucleotide (5’/5 Phos/rCrUrGrUAGGCACCATCAATdi-deoxyC-3 ’) and the 5’ linker 
oligonucleotide (5’-ATCGTrArGrGrCrArCrCrUrGrArArA-3’)] and RT-PCR was carried out. 
 
Figure 1. Overview of the miRNA cloning. See paper body for details. 
Amplification of the cDNA fragments was obtained by two consecutive rounds of PCR. 
Specific restriction enzyme digestion of the adaptors allowed for concatemerization of the 
cDNA into larger fragments. These fragments were then cloned into a vector to create a 
cDNA library. Concatemerization increases the length of informative sequences obtainable 
from each clone. we concatenated more than 20 cDNAs into a single fragment using a BanI 
restriction enzyme (New England Biolabs, Ipswich, MA, USA), a DNA ligation kit ver. 2.1 
(Takara Bio, Shiga, Japan), and a Geneclean III kit (Qbiogene, Irvine, CA, USA) prior to TA 
cloning. The concatenated products were then inserted into plasmids and sequenced (Fig1).  
The sequences were compared to human DNA to determine the genomic origin of the small 
RNA. It was important to avoid contamination from other samples and molecular-weight 
makers during electrophoresis. Such contaminants considerably diminished the accuracy 
and efficiency of miRNA cloning. We avoided contamination by performing the cloning 
procedure separately for each sample, by using a special gel with a small plastic rod that 
divided the sample and marker lanes, and by using separate vats for each gel for ethidium 
bromide staining. We made small RNA libraries by excising a portion of a polyacrylamide 
gel containing species 18–24 nt in length to avoid contaminating our purified RNAs with 
piRNAs (7).  
2.2. Bioinformatics analysis of the sequence data 
We performed a homology search for all cloned small RNAs and a secondary structural 
analysis for all novel miRNA candidates.  
 
Novel microRNA Cloning Using Bioinformatics 279 
2.2.1. Comparing the cloned sequences with those of known RNAs 
The vector sequence, the 5'and 3' linkers, and their coupled sequences 
(CTGTAGGCACCTGAAA) were removed. Those extracted sequences composed of 16–30 nt 
were defined as valid small RNAs and were subjected to followings. The small RNA 
sequences were analyzed for homology with known RNAs, including miRNA, piwi-
interacting (pi) RNA, rRNA, tRNA, small nuclear (sn) RNA, small nucleolar (sno) RNA, and 
mRNA, and human genomic DNA sequences. The databases used were: miRNA (mature- 
and pre-), Sanger Database.; piRNA, the NCBI Entrez Nucleotide database; rRNA, the 
European ribosomal RNA database; tRNA, the Genomic tRNA database; sn/snoRNA, 
RNAdb and NONCODE; mRNA, NCBI Reference Sequence; and human genomic 
sequences, the UCSC Genome Bioinformatics Site. In our searches, we defined the cloned 
sequencing results that had higher than 90% homology as valid if they met our criteria for 
sequence error, erroneous PCR amplification, and 3′- and 5′-end variations. Clones with 
100% homology with human genomic DNA but did not match known RNAs when 
compared to the above databases were termed novel miRNA candidates and were subjected 
to further analysis. The result is shown in table1. 
 
Reads (%) HCC ANL Sum 
Total 314,359 268,708 583,067 
miRNA 256,64 (81.6) 208,038 (77.4) 464,687 (79.7) 
piRNA 2,983 (0.9) 1,440 (0.5) 4,423 (0.8) 
rRNA 5,474 (1.7) 10,161 (3.8) 15,635 (2.7) 
tRNA 1,703 (0.5) 621 (0.2) 2,324 (0.4) 
snRNA 700 (0.2) 343 (0.1) 1,043 (0.2) 
snoRNA 654 (0.2) 747 (0.3) 1,401 (0.2) 
mRNA 6,053 (1.9) 7,279 (2.7) 13,332 (2.3) 
Genome 2,799 (0.9) 3,149 (1.2) 5,948 (1.0) 
Others 15,588 (5.0) 34,686 (12.9) 71,174 (12.2) 
Table 1. Annotation of the sequenced small RNAs 
2.2.2. Secondary structure analysis of Novel microRNAs 
The two-dimensional precursor miRNA (pre-miRNA) configurations of our novel miRNA 
candidates were predicted according to the method described previously (8) with some 
modifications. Briefly, 196-nt of genomic sequence was added to the candidate sequences 
(88-nt at each end). Each candidate sequence was divided into 110-nt windows and 
subjected to two-dimensional analysis along its entire length, using the RNAfold software 
(Vienna RNA Secondary Structure Package (9)). The configurations that had the lowest free 
energy and that had a high conservation (described below) and met the following criteria 
were termed novel miRNAs: (a) contained a stem-loop configuration; (b) cloned mature 
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miRNA sequence portion consisted of more than 16-nt in its double-stranded region; (c) the 
loop contained fewer than 20-nt; (d) the internal loop contained fewer than 10-nt; and (e) the 
bulge contained fewer than 5-nt. Furthermore, novel sequences with overlapping positions 
in the genome were grouped together. Novel antisense miRNAs are defined with above 
criteria (a)-(e) but without conservation score if they are coded in same chromosomal region.  
2.2.3. Determination of hairpin conservation of Novel MicroRNAs 
We classified all the candidate miRNAs using the PhastCon database at the University of 
California at Santa Cruz.(10, 11) This database has scores for each nucleotide in the human 
genome relative to its degree of conservation when compared to nucleotides in the 
armadillo, bush baby, cat, chicken, chimpanzee, cow, dog, elephant, frog, fugu, guinea pig, 
hedgehog, horse, lizard, medaka, mouse, opossum, platypus, rabbit, rat, rhesus monkey, 
shrew, stickleback, tenrec, tetraodon, tree shrew, and zebrafish. The algorithm is based on a 
phylogenetic hidden Markov model that uses best-in-genome pairwise alignment for each 
species (based on BLASTZ), followed by multiple alignment of the twenty eight genomes. A 
hairpin was defined as conserved if the average PhastCon conservation score over the 28 
species for any 15-nt sequence in the hairpin stem was at least 0.8 .(12)  
3. Other techniques for MicroRNAome 
3.1. Real-time PCR analysis of known miRNAs 
Real-time PCR was performed on an ABI7300 (Applied Biosystems, Foster City, CA, USA) 
using various mirVana qRTPCR primer sets (Ambion, Austin, TX, USA) and a SYBR 
ExScript RT-PCR kit (Takara Bio), or with TaqMan miRNAs assays (Applied Biosystems), a 
High capacity cDNA archive kit (Applied Biosystems), and Absolute QPCR ROX mix 
(Abgene, Rochester, NY, USA), according to the manufacturers’ instructions. As an 
endogenous control, 5SrRNA or U6 snRNA was used.  
3.2. Ago2-immunoprecipitation and PCR analysis of novel miRNAs 
After bioinformatic analysis of the sequence data, we further validated novel miRNAs by 
using a combination of Ago2-immunoprecipitation (13) followed by PCR-based miRNA 
detection (14). Briefly, 50 ml Dynabeads protein G slurry (Invitrogen) was immobilized with 
20 mg human P4 anti-mouse Ago2 monoclonal antibody (clone 2D4, Wako Pure Chemical 
Industries, Osaka, Japan). One hundred fifty micrograms of human tissue P4 were 
homogenized in 1.5 ml of a cell lysis solution (provided in miRNAs isolation kit, Wako) 
using a Polytron PT1200C homogenizer (Kinematica AG, Lucerne, Switzerland) for 10 s at 4 
8C, and then 1.5 ml of the cell lysis solution was added into the homogenized solution. 
Following incubation for 15 min on ice, lysate was centrifuged at 20 000 g for 20 min at 4 8C 
and filtered through a 0.8 mmSupor Acrodisc syringe filter (Pall Corporation, Ann Arbor, 
MI, USA). One milliliter of the filtered lysate was incubated with 25 ml of the anti-Ago2-
Dynabead protein G for incubation for 60 min at 4 8C. After immunoprecipitation, Ago2-
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associated RNAs were isolated from the immunoprecipitate according to the manufacture’s 
protocol (Wako). We confirmed that the immunoprecipitate contained human P5 Ago2 
protein of w100 kDa in size by western blot (data not shown). Non-immune human IgG 
(Sigma) was used as a control for Ago2-immunoprecipitation. Preparation of the cDNA 
library using the Ago2-associated RNAs and semi-quantitative PCR analysis of the above-
mentioned novel miRNA candidates were performed, as reported previously (14). A small 
RNA-specific primer and a universal reverse primer RTQ-UNIr (14), were used for 
amplification of each of the small RNAs. The PCR products were analyzed on a 12% 
polyacrylamide gel. The primers for the human GAPDH were used for negative control. 
3.3. PCR analysis of novel miRNAs (Alternative method of 3.2) 
After bioinformatic analysis of the sequence data, we further validated novel miRNAs by 
PCRbased miRNA detection (14). Briefly, small RNAs were isolated using the mirVana™ 
miRNA isolation kit (Ambion). Small RNA samples were polyadenylated with Poly(A) 
Tailing Kit (Ambion) and were purified with Acid-Phenol:Chloroform and with filter 
cartridge provided in the mirVana Probe & Marker Kit (Ambion). To generate a small RNA 
cDNA library, tailed RNA were reverse transcripted using RTQ primer(14) and the samples 
were purified using the QIAquick 
spin PCR purification kit (QIAGEN). A small RNA-specific primer and a universal reverse 
primer RTQ-UNIr (14), were used for amplification of each of the small RNAs. The PCR 
products were analyzed on a 12% polyacrylamide gel. The primers for the human GAPDH 
were used for negative control. 
3.4. Real-time PCR-based miRNA expression profiling 
Total miRNA (350 ng) was reverse-transcribed using Megaplex RT Primers (Applied 
Biosystems). The resulting cDNAs were pre-amplified using Megaplex PreAmp Primers 
(Applied Biosystems) and the pre-amplified products applied to a TaqMan Human 
MicroRNA Array Panel (A and B, v2.0).  
3.5. siRNA, Pre-miR and anti-miR transfections 
Cultured cells were transfected with precursor hsa-miR-200c and hsa-miR-141 (ID: 
PM11714; PM10860); Anti-miR™ 200c and 141 inhibitors (ID: MH11714; MH10860) 
(Ambion, Austin, TX) for 8 hours in serum free medium. Serum supplemented medium was 
added and gene and protein expression measured at the indicated time points. 
4. Study designs 
Sequencing using 454 sequencing and conventional cloning from 22 pair of HCC and 
adjacent normal liver (ANL) and 3 HCC cell lines identified reliable reads of more than 
300000 miRNAs from HCC and more than 270000 from ANL for registered human miRNAs. 
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5. Detected novel microRNAs using cloning 
Eleven novel opposite miRNAs (defined as miRNAs cloned from the other arm of 
precursors from which known miRNAs have been cloned) were identified from the 
annotated miRNAs (Figure 2A).Based on above criteria, a scan of all the novel miRNA 
candidates identified 245 novel precursors, representing putative 210 novel mature miRNAs 
(Figure 2B). 
 
 
 
A: Chromosomal locations of our cloned mature miRNAs which correspond to previously identified pre-miRNAs. The 
bar graphs indicate the location of mature miRNAs (both our cloned miRNAs and previously identified miRNAs) 
based on known pre-miRNA sequences. Many of our cloned sequences were found in these regions. Arrowheads 
indicate novel “opposite” miRNAs cloned in our experiments. These sequences represent mature miRNAs which 
originate on the opposite DNA strand of the known precursor miRNA.  
B: The 222 novel mature miRNAs identified in our study were checked for species conservation using the PhastCon 
database and their corresponding hairpin conservation scores charted in this figure.  
Figure 2. Qualitative analysis of miRNAs in the human liver. 
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Accession 
Number 
Most frequent sequence Strand Chr. 
Precursor 
Start End 
PhastCon 
score 
dG 
(kcal/mol) 
AB372573 TGCAATGGTTGTCCTGAGA + 1 30294032 30294114 0.00 -28.6 
AB372574 GTGGGGGAGAGGCTGTCA + 1 150066781 150066870 0.00 -50.7 
AB372575 TTGCACAACTCTCACATTC + 1 152498870 152498979 0.39 -38.2 
AB372576 CCCCTCACTTCTCCGTCATATC + 1 153367241 153367332 0.05 -28.8 
AB372577 CCCCAGATTCCACACC + 1 154326362 154326427 0.85 -28.9 
Table 2. Summary of the novel miRNAs 
Summary of predicted novel miRNAs. The predicted novel miRNAs with their PhastCon scores are 
listed. And the most frequent cloned sequences, genome locations, clone counts, and conservation 
scores calculated with PhastCon are listed. The stem-loop is a 110-nt sequence derived by 
computational prediction. The precursor structures are listed in Table 3. 
 
 
Table 3. Samples of the Secondary structures of predicted novel miRNAs. The predicted novel miRNAs 
with their particular ID numbers are listed. The mature miRNAs are depicted in blue in the drawing of 
the precursor.  
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We cloned 210 novel microRNA candidates. Samples of the novel microRNAs that were 
detected from our study and its bioinformatics data are tabulated in Table 2 and 3. And 
those novel miRNAs have been deposited with DDBJ under consecutive accession codes 
from AB372573 to AB372814. 
6. Future direction 
We have been demonstrated the usefulness and accuracy of sequencing in genetic 
research of the liver. One of the main problems with applying sequencing to the miRNA 
transcription research is that sequencing is a time-consuming procedure. And an 
important consideration for the discovery of miRNA by sequencing is the difficultly in 
identifying miRNAs that are expressed at low levels, at highly specific stages or in rare 
cell types. Moreover, a serious problem is that some miRNAs are difficult to profile 
precisely due to their physical properties or post-transcriptional modifications, such as 
RNA editing. In principle, these limitations can be overcome by extensive sequencing of 
small RNA libraries from a broad range of samples. For differential display, the 
sequencing-based method has the theoretical advantage in that it has the capability to 
discover and detect novel miRNAs. Based on our sequence variability results, especially 
with regard to RNA modifications, the accuracy of the sequence-based method is 
expected to be superior to that of the hybridization-based method. For the prediction of 
novel miRNAs, methods that rely on phylogenetic 1 genes. To overcome this problem, we 
made use of a computational approach for structural conservation criteria using the 
thermodynamic stability and intrinsic structural features of miRNAs. In clinics, 
pathologists often meet difficult situations in which they cannot clearly tell whether the 
tissue specimens they are observing are malignant or benign. Thus, in our opinion, using 
some miRNAs as a tumor marker would help clinicians to clearly determine whether that 
tissue is cancerous. miRNA sequences followed by bioinformatics have greater power 
than individual miRNAs or other clinic-pathological variables for the detection of high 
risk patients’ groups with poor prognoses. There is currently little data available as to 
how we can use each miRNA to predict high risk groups; however, additional future 
miRNA work and data accumulation will elucidate such criteria. And further 
investigation is warranted to clarify the mechanism of aberrant expression of miRNAs in 
cancer and its participation in carcinogenesis. Nevertheless, these findings show that 
sequence-based miRNA profiling has potential for the confirmation of precise miRNA 
dynamics in a specific disease. In addition, it will increase our understanding of the 
mechanisms and factors involved in human liver cancer. 
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